# FDA recall D-1156-2022

> **Teva Pharmaceuticals USA Inc** · Class II · drug recall initiated 2022-06-14.

## Product

Tretinoin Capsules, 10 mg, Rx Only, 100 capsules per bottle, Teva Pharmaceuticals USA Inc., North Wales, PA, 19454, NDC 0555-0808-02.

## Reason for recall

Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.

## Distribution

Nationwide in the U.S.

## Key facts

- **Recall number:** D-1156-2022
- **Recalling firm:** Teva Pharmaceuticals USA Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-06-14
- **Report date:** 2022-06-29
- **Termination date:** 2023-04-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1156-2022

## Citation

> AI Analytics. FDA recall D-1156-2022. Retrieved 2026-06-12 from https://api.ai-analytics.org/recall/D-1156-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*